These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36529967)

  • 1. Advances in targeting estrogen synthesis and receptors in patients with endometriosis.
    Clemenza S; Vannuccini S; Ruotolo A; Capezzuoli T; Petraglia F
    Expert Opin Investig Drugs; 2022 Nov; 31(11):1227-1238. PubMed ID: 36529967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pharmacological therapies for the treatment of endometriosis.
    Buggio L; Dridi D; Barbara G; Merli CEM; Cetera GE; Vercellini P
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1039-1052. PubMed ID: 36000243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
    Clemenza S; Sorbi F; Noci I; Capezzuoli T; Turrini I; Carriero C; Buffi N; Fambrini M; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():92-101. PubMed ID: 29559388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomyosis: the pathophysiology of an oestrogen-dependent disease.
    Kitawaki J
    Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):493-502. PubMed ID: 16564227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
    Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Chan MS; Miki Y; Saji S; Ueno T; Toi M; Sasano H
    Breast Cancer Res Treat; 2010 Apr; 120(3):639-48. PubMed ID: 20151319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal treatments for endometriosis: The endocrine background.
    Vannuccini S; Clemenza S; Rossi M; Petraglia F
    Rev Endocr Metab Disord; 2022 Jun; 23(3):333-355. PubMed ID: 34405378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of phase II and III drugs for the treatment and management of endometriosis.
    Perrone U; Evangelisti G; Laganà AS; Bogliolo S; Ceccaroni M; Izzotti A; Gustavino C; Ferrero S; Barra F
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):333-351. PubMed ID: 38099328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in pharmacotherapy for treating endometriosis.
    Tafi E; Leone Roberti Maggiore U; Alessandri F; Bogliolo S; Gardella B; Vellone VG; Grillo F; Mastracci L; Ferrero S
    Expert Opin Pharmacother; 2015; 16(16):2465-83. PubMed ID: 26569155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometriosis and nuclear receptors.
    Yilmaz BD; Bulun SE
    Hum Reprod Update; 2019 Jul; 25(4):473-485. PubMed ID: 30809650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
    Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
    Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New medical treatments for endometriosis.
    Olive DL; Lindheim SR; Pritts EA
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):319-28. PubMed ID: 15157645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for
    Salah M; Tahoun M; Rudzitis-Auth J; Stotz L; van Koppen CJ; Laschke MW; Abdelsamie AS; Frotscher M
    J Med Chem; 2023 Jul; 66(13):8975-8992. PubMed ID: 37369108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors in the pharmacotherapy of endometriosis.
    Gardella B; Rispoli E; Pasquali MF; Mauri M; Musacchi V; Dominoni M
    Expert Opin Pharmacother; 2023 Jun; 24(9):1067-1073. PubMed ID: 37128968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis.
    Poirier D; Nyachieo A; Romano A; Roy J; Maltais R; Chai D; Delvoux B; Tomassetti C; Vanhie A
    J Steroid Biochem Mol Biol; 2022 Sep; 222():106136. PubMed ID: 35691460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism.
    Mercorio A; Giampaolino P; Romano A; Dällenbach P; Pluchino N
    Front Endocrinol (Lausanne); 2022; 13():950866. PubMed ID: 36204107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometriosis: the pathophysiology as an estrogen-dependent disease.
    Kitawaki J; Kado N; Ishihara H; Koshiba H; Kitaoka Y; Honjo H
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):149-55. PubMed ID: 12650711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.